Sage Journals: Discover world-class research

Abstract

Sterilisation is one of many methods of contraception available to men and women. Primary care has a key role in sterilisation counselling and referral. This article outlines the risks and benefits of male (vasectomy) and female (laparoscopic tubal occlusion) sterilisation and how they compare to similarly effective methods, particularly long-acting reversible contraception. The article provides an innovative decision-aid algorithm and sterilisation counselling checklist to promote a ‘best practice’ approach.

Get full access to this article

View all access options for this article.

References

ACOG (2019a) ACOG practice bulletin no. 208: Benefits and risks of sterilization. Obstetrics and Gynecology 133(3): e194–e207. DOI: 10.1097/AOG.0000000000003111.

ACOG (2019b) ACOG committee opinion no. 774 summary: Opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention. Obstetrics and Gynecology 133(4): 842–843. DOI: 10.1097/AOG.0000000000003165.

Dilley

Havrilesky

Bakkum-Gamez

, et al.(2017) Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention. Gynecologic Oncology 146(2): 373–379. DOI: 10.1016/j.ygyno.2017.05.034.

Ely

Truong

(2017) The role of opportunistic bilateral salpingectomy vs tubal occlusion or ligation for ovarian cancer prophylaxis. Journal of Minimally Invasive Gynecology 24(3): 371–378. DOI: 10.1016/j.jmig.2017.01.001.

FPA (2018) Your guide to male and female sterilisation. Available at: www.fpa.org.uk/sites/default/files/pdf/FPA Male and Female sterilisation 1007.pdf (accessed 20 July 2020).

FSRH (2017) FSRH press statement: Changes to the provision of fertility and sterilisation services by CCGs. Available at: www.fsrh.org/news/fsrh-press-statement-cuts-fertility-sterilisation-ccgs (accessed 20 July 2020).

FSRH and RCOG (2017) FSRH and RCOG joint statement on Bayer’s decision to discontinue Essure® June 2017. Available at: www.fsrh.org/documents/fsrh-and-rcog-joint-statement-on-bayers-decision-to-discontinue (accessed 20 July 2020).

FSRH Clinical Effectiveness Unit (2014) Male and female sterilisation. Available at: www.fsrh.org/standards-and-guidance/documents/cec-ceu-guidance-sterilisation-cpd-sep-2014 (accessed 20 July 2020).

Hatcher

Nelson

Trussell

, et al.(2018) Contraceptive technology, 21st edition, New York, NY: Ayer Company Publishers, Inc.

10.

Kovacs

Krins

(2002) Female sterilisations with Filshie clips: What is the risk failure? A retrospective survey of 30 000 applications. Journal of Family Planning and Reproductive Health Care 28(1): 34 LP 35. DOI: 10.1783/147118902101195811.

11.

Milton Keynes CCG (2017) Female sterilisation. Available at: www.miltonkeynesccg.nhs.uk/female-sterilisation (accessed 20 July 2020).

12.

NHS Digital (2019) Sexual and reproductive health services (contraception), England, 2018/19. National statistics. Date range: 01 Apr 2018 to 31 Mar 2019. Available at: https://digital.nhs.uk/data-and-information/publications/statistical/sexual-and-reproductive-health-services/2018-19/sterilisations-and-vasectomies (accessed 20 July 2020).

13.

NICE (2016) Clinical knowledge summaries: Contraception - sterilization. Available at: https://cks.nice.org.uk/contraception-sterilization#!topicSummary (accessed 20 July 2020).

14.

North West London Collaboration of CCGs (2018) North West London referral guidelines: Gynaecology. Available at: www.healthiernorthwestlondon.nhs.uk/sites/nhsnwlondon/files/documents/nwl_gynae_referral_guidelines.pdf (accessed 20 July 2020).

15.

RCGP. Clinical topic guide: Sexual health. Available at: www.rcgp.org.uk/training-exams/training/gp-curriculum-overview/document-version.aspx (accessed 20 July 2020).

16.

RCOG (2016) Female sterilisation. Consent advice no.3. Available at: www.rcog.org.uk/globalassets/documents/guidelines/consent-advice/consent-advice-3-2016.pdf (accessed 20 July 2020).